Your browser doesn't support javascript.
loading
Lipid-based nanoparticles as drug delivery carriers for cancer therapy.
Waheed, Ibtesam; Ali, Anwar; Tabassum, Huma; Khatoon, Narjis; Lai, Wing-Fu; Zhou, Xin.
Afiliação
  • Waheed I; Institute of Comparative Medicine, College of Veterinary Medicine, Yangzhou University, Yangzhou, China.
  • Ali A; Department of Applied Biology and Chemical Technology, Hong Kong Polytechnic University, Kowloon, Hong Kong SAR, China.
  • Tabassum H; Department of Biochemical and Biotechnological Sciences, School of Precision Medicine, University of Campania, Naples, Italy.
  • Khatoon N; Institute of Social and Cultural Studies, Department of Public Health, University of the Punjab, Lahore, Pakistan.
  • Lai WF; Department of Biotechnology, Lahore College for Women University, Lahore, Pakistan.
  • Zhou X; Department of Applied Biology and Chemical Technology, Hong Kong Polytechnic University, Kowloon, Hong Kong SAR, China.
Front Oncol ; 14: 1296091, 2024.
Article em En | MEDLINE | ID: mdl-38660132
ABSTRACT
Cancer is a severe disease that results in death in all countries of the world. A nano-based drug delivery approach is the best alternative, directly targeting cancer tumor cells with improved drug cellular uptake. Different types of nanoparticle-based drug carriers are advanced for the treatment of cancer, and to increase the therapeutic effectiveness and safety of cancer therapy, many substances have been looked into as drug carriers. Lipid-based nanoparticles (LBNPs) have significantly attracted interest recently. These natural biomolecules that alternate to other polymers are frequently recycled in medicine due to their amphipathic properties. Lipid nanoparticles typically provide a variety of benefits, including biocompatibility and biodegradability. This review covers different classes of LBNPs, including their characterization and different synthesis technologies. This review discusses the most significant advancements in lipid nanoparticle technology and their use in medicine administration. Moreover, the review also emphasized the applications of lipid nanoparticles that are used in different cancer treatment types.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Oncol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Oncol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China